These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27116176)

  • 41. [Management of urinary tract infections in elderly women--a proposal].
    Rodhe N
    Lakartidningen; 2010 Feb 17-23; 107(7):450; author reply 450-1. PubMed ID: 20384082
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cotrimazine in the treatment of urinary tract infections in infants].
    Dore A; Porcu A; Piga S; Mela MG; Dore AM; Perrotta V
    Clin Ter; 1988 Feb; 124(3):187-92. PubMed ID: 2974330
    [No Abstract]   [Full Text] [Related]  

  • 43. Nitrofurantoin: an effective and ignored antimicrobial.
    Arya SC; Agarwal N; Agarwal S
    Int J Antimicrob Agents; 2006 Apr; 27(4):354-5. PubMed ID: 16531014
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
    Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M
    Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of urinary tract infections unresponsive to sulfa with carbenicillin indanyl sodium.
    Kase S
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):271-5. PubMed ID: 805021
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
    Derevianko II; Lavrinova LN; Kudriashova EE
    Urologiia; 2003; (1):31-4. PubMed ID: 12621964
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of an herbal agent in treatment for Escherichia coli induced bacterial cyctitis in rats.
    Tuken M; Temiz MZ; Yuruk E; Kaptanagasi AO; Basak K; Narter F; Muslumanoglu AY; Sarica K
    Arch Ital Urol Androl; 2017 Jun; 89(2):134-138. PubMed ID: 28679185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of urinary tract infections in children with trimethoprim-sulfamethoxypyridazine].
    Rodríguez W; Delucchi C; Bidegain MA; Rodríguez MS; Gleisner A; Figueroa S
    Rev Chil Pediatr; 1983; 54(6):402-6. PubMed ID: 6379766
    [No Abstract]   [Full Text] [Related]  

  • 51. A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women.
    Gossius G; Vorland L
    Scand J Infect Dis; 1984; 16(4):373-9. PubMed ID: 6396834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment duration for urinary tract infections in adults.
    Gleckman RA
    Antimicrob Agents Chemother; 1987 Jan; 31(1):1-5. PubMed ID: 3551823
    [No Abstract]   [Full Text] [Related]  

  • 53. Intravesical administration of green tea extract attenuates the inflammatory response of bacterial cystitis--a rat model.
    Rosenberg S; Horowitz R; Coppenhagen-Glazer S; Pizov G; Elia A; Gofrit ON; Ginsburg I; Pode D
    BJU Int; 2014 Oct; 114(4):601-7. PubMed ID: 24712880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An in vitro model for assessing optimum antibiotic dosage in urinary tract infection.
    Greenwood D; Kawada Y; O'Grady F
    Infection; 1980; Suppl 1():35-8. PubMed ID: 7399711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
    Bjerrum L; Gahrn-Hansen B; Grinsted P
    Scand J Prim Health Care; 2009; 27(1):6-11. PubMed ID: 18991182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [S3-guideline for uncomplicated urinary tract infections - treatment guidelines compliance].
    Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Knieh E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
    Med Monatsschr Pharm; 2011 May; 34(5):164-8. PubMed ID: 21644375
    [No Abstract]   [Full Text] [Related]  

  • 58. [Nifurpipone in inflammatory diseases of the urinary tract].
    Laudi M; Ferrando V; Fontana G; Sesia G
    Minerva Urol; 1973; 25(3):149-57. PubMed ID: 4583091
    [No Abstract]   [Full Text] [Related]  

  • 59. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 60. [New knowledge in some areas of urinary tract infections in childhood].
    Misselwitz J
    Z Arztl Fortbild (Jena); 1986; 80(10):411-4. PubMed ID: 2875569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.